CA2432504A1 - Methods and compositions for treating periodontal disease - Google Patents

Methods and compositions for treating periodontal disease Download PDF

Info

Publication number
CA2432504A1
CA2432504A1 CA002432504A CA2432504A CA2432504A1 CA 2432504 A1 CA2432504 A1 CA 2432504A1 CA 002432504 A CA002432504 A CA 002432504A CA 2432504 A CA2432504 A CA 2432504A CA 2432504 A1 CA2432504 A1 CA 2432504A1
Authority
CA
Canada
Prior art keywords
phenyl
methyl
cox
pharmaceutically acceptable
methylsulfonyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002432504A
Other languages
English (en)
French (fr)
Inventor
George D. Hartman
Sevgi B. Rodan
Gideon A. Rodan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2432504A1 publication Critical patent/CA2432504A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Furan Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CA002432504A 2001-01-03 2001-12-28 Methods and compositions for treating periodontal disease Abandoned CA2432504A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US25944101P 2001-01-03 2001-01-03
US60/259,441 2001-01-03
PCT/US2001/049638 WO2002053099A2 (en) 2001-01-03 2001-12-28 Methods and compositions for treating periodontal disease

Publications (1)

Publication Number Publication Date
CA2432504A1 true CA2432504A1 (en) 2002-07-11

Family

ID=22984959

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002432504A Abandoned CA2432504A1 (en) 2001-01-03 2001-12-28 Methods and compositions for treating periodontal disease

Country Status (5)

Country Link
EP (1) EP1349548A4 (https=)
JP (1) JP2004517853A (https=)
AU (1) AU2002246757B2 (https=)
CA (1) CA2432504A1 (https=)
WO (1) WO2002053099A2 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201305668D0 (en) 2013-03-28 2013-05-15 Glaxosmithkline Ip Dev Ltd Avs6 Integrin Antagonists
PL3050878T3 (pl) 2013-09-24 2022-01-24 Fujifilm Corporation Zawierający atom azotu związek lub jego sól, lub ich kompleks z metalem
GB201417011D0 (en) 2014-09-26 2014-11-12 Glaxosmithkline Ip Dev Ltd Novel compounds
GB201417094D0 (en) 2014-09-26 2014-11-12 Glaxosmithkline Ip Dev Ltd Novel compounds
GB201417002D0 (en) 2014-09-26 2014-11-12 Glaxosmithkline Ip Dev Ltd Novel compound
GB201417018D0 (en) 2014-09-26 2014-11-12 Glaxosmithkline Ip Dev Ltd Novel compounds
GB201604680D0 (en) 2016-03-21 2016-05-04 Glaxosmithkline Ip Dev Ltd Chemical Compounds

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5190981A (en) * 1989-08-17 1993-03-02 Sepracor Inc. Formulation containing S(+) enantiomer of flurbiprofen or ketoprofen and method of use for oral administration for prevention and treatment of bone loss associated with periodontal disease
US20020028798A1 (en) * 1995-12-12 2002-03-07 Omeros Medical Systems Irrigation solution and method for inhibition of pain and inflammation
US6048861A (en) * 1997-12-17 2000-04-11 Merck & Co., Inc. Integrin receptor antagonists
TR200001752T2 (tr) * 1997-12-17 2000-12-21 Merck & Co., Inc. Entegrin reseptör antagonistleri
US6017926A (en) * 1997-12-17 2000-01-25 Merck & Co., Inc. Integrin receptor antagonists
US6136804A (en) * 1998-03-13 2000-10-24 Merck & Co., Inc. Combination therapy for treating, preventing, or reducing the risks associated with acute coronary ischemic syndrome and related conditions
AU747784B2 (en) * 1998-07-29 2002-05-23 Merck & Co., Inc. Integrin receptor antagonists
PT1187592E (pt) * 1999-06-02 2007-10-19 Merck & Co Inc Antagonistas dos receptores de integrina alfa v

Also Published As

Publication number Publication date
WO2002053099A2 (en) 2002-07-11
AU2002246757B2 (en) 2006-02-02
JP2004517853A (ja) 2004-06-17
EP1349548A2 (en) 2003-10-08
WO2002053099A3 (en) 2002-09-12
EP1349548A4 (en) 2004-06-02

Similar Documents

Publication Publication Date Title
US6384034B2 (en) Method of treating migraines and pharmaceutical compositions
KR100671392B1 (ko) 항균제로서의 화합물의 신규한 용도
HU203670B (en) Process for producing pharmaceutical composition containing basically modificated insuline derivatives and zinc-ions for treating diabetes mellitus
CA2345641A1 (en) A method for treating inflammatory diseases by administering a thrombin inhibitor
WO2000002555A1 (en) Methods and compositions for the treatment of chronic lymphocytic leukemia
US20080234337A1 (en) Preventive and/or Remedy for Hyperkalemia Containing Ep4 Agonist
AU2002246757B2 (en) Methods and compositions for treating periodontal disease
US20020040039A1 (en) Treatment of inflammation with a combination of a cyclooxygenase-2 inhibitor and an integrin alpha-v antagonist
US20040053968A1 (en) Methods and compositions for treating peridontal disease
US20040186155A1 (en) Combination therapy for the treatment or prevention of migraine
AU2002246757A1 (en) Methods and compositions for treating periodontal disease
GB2324726A (en) Combination Therapy for the Treatment of Osteoporosis
WO2008112167A1 (en) Combination of metformin r-(+) lipoate and antihypertensive agents for the treatment of diabetic hyperglycemia and diabetic complications
JPWO2006016689A1 (ja) Ｅｐ４アゴニストを含有してなる下部尿路系疾患の予防および／または治療剤
US7358254B2 (en) Method for treating atherosclerosis employing an aP2 inhibitor and combination
HU203970B (en) Process for producing pharmaceutical compositions comprising 3-substituted-2-oxidol-1-carboxamide derivatives as active ingredient
JP2006096665A (ja) 脊柱管狭窄症治療剤
RU2336872C2 (ru) Аннелированные пиррольные соединения как ингибиторы протонового насоса для лечения язвы
JP6824015B2 (ja) 歯槽骨吸収抑制剤
WO2020139784A1 (en) Method to prevent and treat gingival recession by calcium channel blockers, angiotensin converting enzyme inhibitors, and angiotensin receptor blockers
RS55774B1 (sr) Kombinacija (3s,3s') 4,4'-disulfandiilbis(3-aminobutan 1-sulfonske kiseline) i nekog drugog antihipertenzivnog agensa
JP2005503346A (ja) 片頭痛を治療するための方法及び組成物
IL95880A (en) Use of 3-Transformed History of 2-Oxindole for the Preparation of Pharmaceuticals for Inhibition of Interlaukio-1 Biosynthesis
AU3948699A (en) Use of a cox-2 inhibitor and a nk-1 receptor antagonist for treating inflammation
US20070167510A1 (en) Methods for inhibiting osteoclastogenesis

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead